$53.13
-0.35(-0.66%)
Mkt Cap $8.3B
$46.66
$71.38
52-Week Range
At A Glance
1
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide.
2
Revenue is primarily driven by Consumables (67.1%) and Product And Services (27.4%).
3
Most recently: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Officer Trans (2026-02-11).
$8.3B
Market Cap
$1.2B
Revenue
$81M
Net Income
Employees3,100
Fundamentals
How The Business Makes Money
Revenue by Segment
Consumables67.1%($8.5B)
Product And Services27.4%($3.4B)
Instruments2.6%($332M)
Service2.4%($297M)
Royalty0.5%($68M)
Revenue by Geography
US56.4%($2.0B)
EMEA Excluding UK20.7%($728M)
CN8.9%($314M)
APAC Excluding Greater China6.4%($224M)
GB4.4%($154M)
Rest Of World3.2%($112M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0000842023
ISINUS09073M1045
CUSIP09073M104
Phone612 379 8854
Address614 McKinley Place N.E., Minneapolis, MN, 55413, US
SEC EDGAR